Bloom Energy partially retraced last week's 11% drop, adding 4.2% on Tuesday to close at $243.40 — but the more remarkable shift this week happened in the lending market, where short sellers cut their positions by nearly 38% in a single week.
The short-covering story is the standout. Short interest fell from roughly 29 million shares to 18.3 million between July 9 and July 10 — a one-day cliff drop of nearly 10 million shares — bringing SI % of free float down to 7.7%, from a level above 12% just days earlier. That's the fastest unwind in the 30-day history available. Borrow costs have followed: the cost to borrow is now 0.25%, down 40% on the week and almost half what it was a month ago. Availability has swung dramatically in the same direction — from roughly 1,963 shares available per 100 shorted in late June to over 4,100 today, meaning the lending pool is now extremely loose. Shorts retreating ahead of July 28 earnings appears to be the dominant dynamic, and the borrow data confirms they're not just closing — the exit is fast and orderly.
Options positioning offers a mild counterpoint. Put/call ratio is running at 1.22, slightly below its 20-day average of 1.29 and a full standard deviation below that mean, meaning options traders are actually a touch less defensively positioned than usual. That's notable given where the PCR was in late June — touching 1.43 on June 24 — and represents a clear easing of near-term hedging pressure even as the print approaches. The stock has now slid back below the mean analyst target of $283, as it was last week, and Tuesday's bounce barely dented that gap.
The Street picture is crowded with cautious bulls. Several firms lifted targets over the past two weeks: Susquehanna raised to $298 (from $293), Baird reiterated Outperform at $310, and UBS carries a $350 Buy from July 1 — all well above the current print. Against those, Truist initiated on July 14 at Hold with a $250 target, below where the stock trades, and Jefferies holds at $246 on a Hold rating. Consensus sentiment leans cautious overall despite the target cluster sitting at $283. Factor scores reinforce a bifurcated picture: EPS momentum ranks in the 99th percentile over 90 days, EPS surprise in the 91st, and forward EPS growth in the 100th — all pointing to an extraordinary earnings revision cycle. The short score, however, has dropped sharply to 39 from 47 a week ago, reflecting the rapid unwind of short positioning.
Insider activity adds a layer of complexity. The net 90-day insider figure looks positive at first glance — net shares acquired of roughly 228,600 — but the composition is almost entirely an 80,000-share CEO award to founder K.R. Sridhar in May. Open-market selling has dominated actual cash transactions: director John Chambers sold $16.4 million in shares on May 28, and the Chief Commercial Officer sold twice in June and July at prices between $289 and $300, well above current levels. That cluster of executive selling near the recent highs is worth noting as the stock works to reclaim that ground.
Earnings reactions have been wide and volatile. The April 28 print generated a 22.7% next-day gain and a 25.8% five-day move. The May 7 report went the other direction — down 8.6% the next day before recovering 6.3% over the week. The May 21 event produced a more modest 7.1% gain. Three prints, three different outcomes, none of them small. With shorts now unwound and the borrow market loose, what the July 28 report removes is any obvious short-squeeze dynamic — the next move will be driven by whether the earnings itself justifies a stock that still trades at 103x trailing earnings and 81x EV/EBITDA.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
